STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] uniQure N.V. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

RTW Investments, LP and Roderick Wong report a passive 9.4% stake in uniQure (QURE), holding 5,158,231 ordinary shares. The holdings are held directly by the RTW Funds and RTW Investments and Dr. Wong report shared voting and dispositive power over all 5,158,231 shares and report no sole voting or dispositive power. The percentage is calculated using 54,865,673 shares outstanding as reported for the period cited in the filing. The statement is made on a Schedule 13G basis and includes a certification that the shares were acquired and are held in the ordinary course of business and not to change or influence control of the issuer.

Positive
  • RTW Investments and Dr. Roderick Wong report ownership of 5,158,231 shares, representing a material 9.4% stake
  • Holdings are reported as held on behalf of the RTW Funds with shared voting and dispositive power
  • Filing is on Schedule 13G with a certification that shares were acquired in the ordinary course and not to change control
Negative
  • None.

Insights

RTW holds a materially large passive position (9.4%) in uniQure, signaling notable institutional exposure without activist intent.

RTW Investments and Dr. Roderick Wong report ownership of 5,158,231 shares, representing 9.4% of the 54.9 million shares outstanding referenced in the filing. The filing is a Schedule 13G, and Item 10 contains the standard certification that the position was acquired and is held in the ordinary course of business and not for the purpose of changing control. The reported shared voting and dispositive power (and zero sole power) indicates influence through pooled fund holdings rather than individual control. For investors, this documents significant institutional interest but does not signal an imminent activist campaign.

Schedule 13G classification confirms passive intent; 9.4% stake gives material voice in shareholder matters but no sole control.

The reporting persons are RTW Investments (an investment adviser to the RTW Funds) and Dr. Roderick Wong (Managing Partner/Chief Investment Officer). Both report shared voting and dispositive power over 5,158,231 shares and no sole powers. The filing identifies the shares as held on behalf of the RTW Funds and uses 54,865,673 shares outstanding as the denominator. From a governance perspective, a near-10% stake is material to votes and proposals, but the Schedule 13G framework here documents a non-control posture under the representations in Item 10.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



RTW Investments, LP
Signature:/s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D., Managing Partner
Date:08/14/2025
Roderick Wong
Signature:s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D.
Date:08/14/2025

FAQ

How many uniQure (QURE) shares does RTW Investments report owning?

The filing reports 5,158,231 shares beneficially owned by RTW Investments and Roderick Wong.

What percentage of uniQure does the reported stake represent?

The reported position represents 9.4% of the outstanding shares based on 54,865,673 shares used in the filing's calculation.

Is this a Schedule 13G or 13D filing for QURE?

This is a Schedule 13G (Amendment No. 1) filed by RTW Investments and Roderick Wong, indicating a passive investor filing under the applicable rule.

Do the reporting persons have sole voting or dispositive power over the shares?

No. The filing shows 0 sole voting power and 0 sole dispositive power and 5,158,231 shared voting and dispositive power.

On whose behalf are the shares held?

The shares are held directly by the RTW Funds, for which RTW Investments serves as investment adviser.
Uniqure

NASDAQ:QURE

QURE Rankings

QURE Latest News

QURE Latest SEC Filings

QURE Stock Data

1.74B
58.43M
6.08%
96.92%
16.51%
Biotechnology
Pharmaceutical Preparations
Link
Netherlands
AMSTERDAM